ALGN - Latest News
Align Technology, Inc. (ALGN), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $12.99B. Trailing twelve-month P/E ratio is 31.33. Beta to the broader market is 1.65.
The article list below shows the most recent ALGN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ALGN Headlines
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
zacks.com - Aug 14, 2026
ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious
Align Technology Prevails in China Patent Infringement Action Against Angelalign
gurufocus.com - Aug 11, 2026
Align Technology, Inc.
Align Technology Prevails in China Patent Infringement Action Against Angelalign
businesswire.com - Aug 11, 2026
SAN JOSE, Calif. & TEMPE, Ariz.
Contravisory Investment Management Inc. Makes New $1.11 Million Investment in Align Technology, Inc. $ALGN
defenseworld.net - Aug 10, 2026
Contravisory Investment Management Inc. acquired a new stake in Align Technology, Inc.
Align Technology, Inc. $ALGN Shares Sold by Assenagon Asset Management S.A.
defenseworld.net - Aug 8, 2026
Assenagon Asset Management S. A.
How News Affects ALGN Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ALGN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ALGN news questions
- What is the latest ALGN news headline?
- The most recent ALGN headline (Aug 14, 2026) is "Should Investors Buy Align as Growth Meets Valuation and Demand Risks?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ALGN news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ALGN news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ALGN options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.